http://purl.org/np/RAa5ZPrqWnvi22gw9CwFa8VhbG8-1XrRqahWW1-rWt34Q
.trig | .trig.txt | .jelly | .jelly.txt
@prefix this: <http://purl.org/np/RAa5ZPrqWnvi22gw9CwFa8VhbG8-1XrRqahWW1-rWt34Q> .
@prefix sub: <http://purl.org/np/RAa5ZPrqWnvi22gw9CwFa8VhbG8-1XrRqahWW1-rWt34Q#> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix pav: <http://purl.org/pav/> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix infores: <https://w3id.org/biolink/infores/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix orcid: <https://orcid.org/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix biolink: <https://w3id.org/biolink/vocab/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix npx: <http://purl.org/nanopub/x/> .
sub:Head {
this: a np:Nanopublication;
np:hasAssertion sub:assertion;
np:hasProvenance sub:provenance;
np:hasPublicationInfo sub:pubInfo .
}
sub:assertion {
<http://identifiers.org/pubchem.compound/53232> a biolink:ChemicalEntity;
rdfs:label "Lovastatin";
biolink:category biolink:ChemicalEntity .
<http://identifiers.org/pubchem.compound/5997> a biolink:ChemicalEntity;
rdfs:label "cholesterol";
biolink:category biolink:ChemicalEntity .
<http://purl.obolibrary.org/obo/CHEBI_26607> a biolink:ChemicalEntity;
rdfs:label "saturated fat";
biolink:category biolink:ChemicalEntity .
<http://purl.obolibrary.org/obo/MONDO_0005068> a biolink:DiseaseOrPhenotypicFeature;
rdfs:label "Myocardial infarction";
biolink:category biolink:DiseaseOrPhenotypicFeature .
<http://purl.obolibrary.org/obo/MONDO_0006805> a biolink:DiseaseOrPhenotypicFeature;
rdfs:label "Unstable angina";
biolink:category biolink:DiseaseOrPhenotypicFeature .
sub:_1 a biolink:Association;
rdf:object <http://purl.obolibrary.org/obo/MONDO_0005068>;
rdf:predicate biolink:treats;
rdf:subject <http://identifiers.org/pubchem.compound/53232>;
biolink:aggregator_knowledge_source infores:knowledge-collaboratory;
biolink:category biolink:Association;
biolink:publications <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=acbce0e8-5098-4785-943b-8bdb5ff17fab> .
sub:_2 a biolink:Association;
rdf:object <http://identifiers.org/pubchem.compound/5997>;
rdf:predicate biolink:treats;
rdf:subject <http://identifiers.org/pubchem.compound/53232>;
biolink:aggregator_knowledge_source infores:knowledge-collaboratory;
biolink:category biolink:Association;
biolink:publications <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=acbce0e8-5098-4785-943b-8bdb5ff17fab> .
}
sub:provenance {
sub:assertion prov:generatedAtTime "2022-10-11T07:30:52.676958"^^xsd:dateTime;
prov:wasAttributedTo orcid:0000-0002-3668-2627;
prov:wasQuotedFrom "Lovastatin tablets USP should be used in addition to a diet restricted in saturated fat and cholesterol as part of a treatment strategy to lower total-C and LDL-C to target levels when the response to diet and other nonpharmacological measures alone has been inadequate to reduce risk. The tablets are indicated to reduce the risk of:: Myocardial infarction-Unstable angina; Coronary revascularization procedures." .
biolink: pav:version "2.3.0" .
}
sub:pubInfo {
sub:sig npx:hasAlgorithm "RSA";
npx:hasPublicKey "MIIBIjANBgkqhkiG9w0BAQEFAAOCAQ8AMIIBCgKCAQEApdULbl+/+pkVlq0fAzWmzfgIb+XMuQPKHMDVzUTWCZBjLfzORll42ptr52e4w7tTYkUKrBsQbx8lkjZWAlWiyh+xIK0oLFSdYRSt63kgiyRYBUOR+spcgmofb7f6JyftArPVTKhsWOMt/mcyNG9qc3lw8B/xuPmLteUWO33xWhfXQreTw1lsGUkZ1j4cB4X9HIuI20ktLYLCXaBauNHEJZ4qp6/Q2ATsJcw8tg7aRmFKXhrjM9maZ2+0cMg0Jpmn2UnDlPKXEA6Qq+qnvvQt8KFjIzP9FTMyvrWl8tTd0NCmS9VpooZJQ8We1lGMPXg5bMbe/bVkTf70fbFMf0RKrQIDAQAB";
npx:hasSignature "ZLKluXDpW1Yw2H8AkHLWrrwRqzU1UlFuruoneNNQsSSHwj+yuDnCzn1eZEsYmYam9tlqk+gQXXsCcCkjFi3FKOTzTJ+boZA9ybKjRa1IXUkGtTSAiaUJgQtCqd0xMYHjb+kUbiGSdQ9A79FRICs5ttrUWefz54xkUr511hQq4hQeiYLyNrtYUIBYxflATPoIEyBJD4NT+v7SKUC9YY5fqki+TPB9+4aVmj4zTz3WLzrSRPtmjDE+GQICW+4weBBa/PbkwTqmDDygABSCVo8gbwTlmZ+r3IvRbGqOuERc7/Mgx90JooIvfb1mreoKXjCLAgiy+hHRkXdcM8/m5oWWiQ==";
npx:hasSignatureTarget this: .
this: prov:generatedAtTime "2022-10-11T07:30:52.676958"^^xsd:dateTime;
prov:wasAttributedTo orcid:0000-0002-3668-2627 .
}